STEPHANIE ORIHOOD: Open Payments
NPI 1538796685 · GARNER, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$903 in 50 payments from 15 companies in 2025. Trend: 2023 $1,525 · 2024 $346 · 2025 $903
Food & beverage: $903
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 15 | $274 |
| E.R. Squibb & Sons, L.L.C. | 4 | $80 |
| Otsuka America Pharmaceutical, Inc. | 4 | $75 |
| ABBVIE INC. | 4 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $65 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| Bausch Health US, LLC | 3 | $53 |
| Neurocrine BioSciences, Inc. | 3 | $50 |
| Supernus Pharmaceuticals, Inc. | 3 | $46 |
| Tris Pharma Inc | 2 | $42 |
Products named: HETLIOZ, REXULTI, COBENFY, VRAYLAR, CAPLYTA, Auvelity, APLENZIN, INGREZZA.
Industry payments across NC — which companies pay providers there.
